Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$14.43
0.564.04%
Last update: Dec 15, 9:15 AM
Comments
Loading...
Edge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Regenxbio (RGNX) stock?
You can purchase shares of Regenxbio (NASDAQ:RGNX) through any online brokerage.
Who are Regenxbio (RGNX) competitors?
Other companies in Regenxbio’s space includes: Bright Minds Biosciences Inc (NASDAQ:DRUG), CytomX Therapeutics Inc (NASDAQ:CTMX), Gyre Therapeutics Inc (NASDAQ:GYRE), 4D Molecular Therapeutics Inc (NASDAQ:FDMT) and Cullinan Therapeutics Inc (NASDAQ:CGEM).
What is the forecast, or price target, for Regenxbio (RGNX) stock?
Regenxbio has a consensus price target of $30.79.
What is the current price for Regenxbio (RGNX)?
The stock price for Regenxbio (NASDAQ: RGNX) is $14.43 last updated December 15, 2025 at 9:15 AM EST.
Does Regenxbio (RGNX) pay a dividend?
There are no upcoming dividends for Regenxbio.
When is Regenxbio (NASDAQ:RGNX) reporting earnings?
Regenxbio does not have any upcoming earnings scheduled.
Is Regenxbio (RGNX) going to split?
There is no upcoming split for Regenxbio.
What sector and industry does Regenxbio (RGNX) operate in?
Regenxbio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
